Accès au site français Welcome to You buy France The french suppliers portal


twitter linkedin facebook viadeo

You buy France


Health and the understanding of the mechanisms underlying Life Sciences have been key issues for our societies for ages.

In most of the problems related to health and to the understanding of living organisms, chemistry and more precisely organic synthesis remains the cornerstone. Indeed health domains always need new molecules to explore the molecular space and find the drug of the future. On the other hand, new tools to characterize or understand biological mechanisms are still sought by the scientific community. In this internationally competitive area, our LABEX application SYNORG proposes to associate the four A-ranked laboratories of organic synthesis, two in Normandie regions (LCMT at Caen and COBRA at Rouen) and two in region “Centre” (ICOA at Orléans and GICC at Tours), representing more than 175 permanent staff people.

SYNORG will become the framework of academic research in PharmaValley, the biggest concentration of pharmaceutical industries within Europe. SYNORG will then be the biggest French laboratory of organic synthesis, allowing it to address, in a more efficient manner, all challenges in synthetic methodology for applications in Life Sciences and to open the way to the discovery and synthesis of new pharmacologically important scaffolds. Bringing together these four laboratories will allow this LABEX to reach the critical size to internationally compete and attract foreign researchers and students. This LABEX aims at increasing international recognition and appearing as an unavoidable partner in synthetic chemistry for Life Sciences. SYNORG will focus on 4 main axes, based on the common or complementary specificities and recognized expertise of the different partners: Heteroelements’ chemistry, Metal-mediated chemistry, Heterocyclic chemistry, Carbohydrate chemistry.

Three bottlenecks and challenges in Life Sciences could be addressed to by the methodological expertise of the SYNORG:

Development of new synthetic methodologies and new reactions sequences leading efficiently to novel, unprecedented families of compounds.
Innovative methods for bioconjugate chemistry and labeling techniques
Development of environmentally friendly reaction sequences.

+ Read more


Company profile

Related activities :

Energy, chemistry, materials

Health, pharmacy, life sciences

Export area :

Local presence :

Target countries :

European Union

North America

North Asia

More information

Social network










Business France contributes to the development and success of French and foreign businesses wishing to expand abroad by supporting them throughout the lifetime of their projects, and is driven by an efficient, result-oriented working culture. > Read more


Discover the French know how:



Rail industry